ESR1 and breast cancer: Given the sex‐based differences in ER expression, female and male BC patients exhibit distinct gene expression profiles and immune microenvironments, leading to poorer survival outcomes for female patients than for their male counterparts.[2, 161] Similar to AR, ER can also induce inflammation to promote prostate carcinogenesis.